Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × HER2 Negative Breast Cancer × Letrozole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 196 Polycystic Ovary Syndrome 32 Endometrial Neoplasms 14 Ovarian Neoplasms 13 Neoplasm Metastasis 9 Infertility 8 Fallopian Tube Neoplasms 6 Carcinoma, Intraductal, Noninfiltrating 6 Osteoporosis 4 Neoplasms 4 Leiomyoma 4 Infertility, Female 4 Breast Neoplasms, Male 4 Breast Diseases 4 Arthralgia 4 Advanced Breast Cancer 4 Triple Negative Breast Neoplasms 3 Recurrence 3 Obesity 3 Breast Carcinoma In Situ 3 Breast Cancer Metastatic 3 Uterine Neoplasms 2 Solid Tumor 2 Prostatic Neoplasms 2 Progesterone Resistance 2 Pancreatic Neoplasms 2 Pain 2 Leiomyosarcoma 2 Estrogen Receptor-positive Breast Cancer 2 Endometrial Hyperplasia 2

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06953882 2025-07-14

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡